Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled, Crossover Trials
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate topiramate in adults with essential tremor. METHODS: This report represents the combined results of 3 randomized, double-blind, placebo-controlled, crossover trials that followed a common protocol. Study subjects were adults (> or =18 years old) who had untreated or treated moderate to severe essential tremor involving upper extremities. Patients were randomized to a double-blind sequence of topiramate (400 mg/d or maximum tolerated dose) then placebo (n = 30) or placebo then topiramate (n = 32). A 2-week washout period separated 10-week double-blind treatment phases. Upper extremity tremor was assessed using the Fahn-Tolosa-Marin tremor rating scale (TRS). The primary efficacy measure was the TRS total score at the final visit for patients providing on-treatment data in both double-blind treatment periods. Secondary efficacy measures included change from baseline in TRS total score and in TRS subscale scores for tremor severity, motor task performance, and functional disability. RESULTS: A total of 62 patients were enrolled. Total tremor score was significantly (P < 0.0001) lower with topiramate (28.7 +/- 1.0) vs placebo (37.0 +/- 1.0). The change from baseline in TRS total and subscale scores was significantly greater (P < or = 0.005) with topiramate treatment (mean score reduction, 7.7-11.8 vs 0.08-2.0). Of the 28 patients who discontinued without completing both treatment periods, adverse events accounted for 13 of 18 discontinuations during topiramate treatment and 5 of 10 discontinuations during placebo exposure. Adverse events reported by 2 or more patients discontinuing topiramate were nausea (n = 3), paresthesia (n = 3), and concentration/attention difficulty (n = 2). CONCLUSIONS: Topiramate was associated with overall tremor reduction and improvements in tremor severity, motor task performance, and functional disability in patients with moderate to severe essential tremor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Statement of the Movement Disorder Society on Tremor
Deuschl, G., Bain, P., & Brin, M. (2008) · Movement Disorders · doi:10.1002/mds.870131303 · Cited by 1,981
Essential tremor frequency decreases with time
Elble, R. J. (2000) · Neurology · doi:10.1212/wnl.55.10.1547 · Cited by 166
Benefits and Risks of Pharmacological Treatments for Essential Tremor
Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., et al. (2003) · Drug Safety · doi:10.2165/00002018-200326070-00003 · Cited by 103 · cited 1×
“Propranolol and primidone reduce symptoms in 50% to 70% of patients with essential tremor, although their usefulness can be limited by loss of therapeutic effect over time, side effects, and interactions with medications commonly used in elderly patients (eg, digoxin, calcium channel blockers, and antiarrhythmics).(2,…”
Background
Cited by
Treatment of patients with essential tremor
Deuschl, G., Raethjen, J., Hellriegel, H., & Elble, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70322-7 · Cited by 428
Zesiewicz, T. A., Elble, R., Louis, E. D., Hauser, R. A., Sullivan, K. L., Dewey, R. B., Ondo, W. G., Gronseth, G. S., & Weiner, W. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163769.28552.cd · Cited by 371
Zesiewicz, T. A., Elble, R. J., Louis, E. D., Gronseth, G. S., Ondo, W. G., Dewey, R. B., Okun, M. S., Sullivan, K. L., & Weiner, W. J. (2011) · Neurology · doi:10.1212/wnl.0b013e318236f0fd · Cited by 348
Essential tremor: diagnosis and management
Shanker, V. (2019) · BMJ · doi:10.1136/bmj.l4485 · Cited by 182
Review: Diagnosis and management of essential tremor and dystonic tremor
Gironell, A., & Kulisevsky, J. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609104791 · Cited by 41
Metadata
- Authors
- Connor, G. S., Edwards, K., & Tarsy, D.
- Venue
- Clinical Neuropharmacology
- Published
- 2008-03
- Volume
- 31
- Issue
- 2
- Pages
- 97-103
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W1965458813
- Cited by
- 63
- References
- 3
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled, Crossover Trials. https://app.cochat.ai/papers/10.1097/wnf.0b013e3180d09969
- The paper
- Connor, G. S., Edwards, K., & Tarsy, D. (2008). Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled, Crossover Trials. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0b013e3180d09969
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.